177 related articles for article (PubMed ID: 38515278)
1. PROM2 overexpression induces metastatic potential through epithelial-to-mesenchymal transition and ferroptosis resistance in human cancers.
Paris J; Wilhelm C; Lebbé C; Elmallah M; Pamoukdjian F; Héraud A; Gapihan G; Walle AV; Tran VN; Hamdan D; Allayous C; Battistella M; Van Glabeke E; Lim KW; Leboeuf C; Roger S; Falgarone G; Phan AT; Bousquet G
Clin Transl Med; 2024 Mar; 14(3):e1632. PubMed ID: 38515278
[TBL] [Abstract][Full Text] [Related]
2. LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer.
Luo W; Wang J; Xu W; Ma C; Wan F; Huang Y; Yao M; Zhang H; Qu Y; Ye D; Zhu Y
Cell Death Dis; 2021 Nov; 12(11):1043. PubMed ID: 34728613
[TBL] [Abstract][Full Text] [Related]
3.
Wu KL; Chang CY; Tsai YM; Lai JC; Hung JY; Lin YS; Tsai PH; Hsu YL
Am J Cancer Res; 2024; 14(4):1561-1576. PubMed ID: 38726259
[TBL] [Abstract][Full Text] [Related]
4. Regulation of tumorigenesis and ferroptosis in non-small cell lung cancer by a novel BBOX1-AS1/miR-326/PROM2 axis.
An J; Shi J; Yang C; Luo J; Li Y; Ren J; Lv Y; Zhang Y
Mol Cell Biochem; 2023 Aug; ():. PubMed ID: 37639200
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics, RNA sequencing, and targeted bisulfite sequencing analyses identify the role of PROM2 as a diagnostic and prognostic biomarker.
Uqaili AA; Usman G; Bhatti U; Nasir H; Zia R; Akram MA; Jawad FA; Farid A; AbdelGawwad MR; Almutairi SM; Elshikh MS; Hussain S; Rasheed RA
Am J Transl Res; 2023; 15(8):5389-5407. PubMed ID: 37692961
[TBL] [Abstract][Full Text] [Related]
6. Gambogenic acid induces ferroptosis in melanoma cells undergoing epithelial-to-mesenchymal transition.
Wang M; Li S; Wang Y; Cheng H; Su J; Li Q
Toxicol Appl Pharmacol; 2020 Aug; 401():115110. PubMed ID: 32533954
[TBL] [Abstract][Full Text] [Related]
7. Hsa_circ_0057105 modulates a balance of epithelial-mesenchymal transition and ferroptosis vulnerability in renal cell carcinoma.
Cen J; Liang Y; Feng Z; Chen X; Chen J; Wang Y; Zhu J; Xu Q; Shu G; Zheng W; Liang H; Wang Z; Deng Q; Cao J; Luo J; Jin X; Huang Y
Clin Transl Med; 2023 Aug; 13(8):e1339. PubMed ID: 37496319
[TBL] [Abstract][Full Text] [Related]
8. Prominin-2 expression increases protrusions, decreases caveolae and inhibits Cdc42 dependent fluid phase endocytosis.
Singh RD; Schroeder AS; Scheffer L; Holicky EL; Wheatley CL; Marks DL; Pagano RE
Biochem Biophys Res Commun; 2013 May; 434(3):466-72. PubMed ID: 23583380
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer.
Lee J; You JH; Kim MS; Roh JL
Redox Biol; 2020 Oct; 37():101697. PubMed ID: 32896720
[TBL] [Abstract][Full Text] [Related]
10. PROM1 and PROM2 expression differentially modulates clinical prognosis of cancer: a multiomics analysis.
Saha SK; Islam SMR; Kwak KS; Rahman MS; Cho SG
Cancer Gene Ther; 2020 Apr; 27(3-4):147-167. PubMed ID: 31164716
[TBL] [Abstract][Full Text] [Related]
11. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation.
Chen P; Li X; Zhang R; Liu S; Xiang Y; Zhang M; Chen X; Pan T; Yan L; Feng J; Duan T; Wang D; Chen B; Jin T; Wang W; Chen L; Huang X; Zhang W; Sun Y; Li G; Kong L; Chen X; Li Y; Yang Z; Zhang Q; Zhuo L; Sui X; Xie T
Theranostics; 2020; 10(11):5107-5119. PubMed ID: 32308771
[No Abstract] [Full Text] [Related]
12. Prominin 2 decreases cisplatin sensitivity in non-small cell lung cancer and is modulated by CTCC binding factor.
Tang J; Shu D; Fang Z; Yang G
Radiol Oncol; 2023 Sep; 57(3):325-336. PubMed ID: 37665741
[TBL] [Abstract][Full Text] [Related]
13. Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cells.
Leontovich AA; Zhang S; Quatraro C; Iankov I; Veroux PF; Gambino MW; Degnim A; McCubrey J; Ingle J; Galanis E; D'Assoro AB
Int J Oncol; 2012 Jun; 40(6):1858-64. PubMed ID: 22447278
[TBL] [Abstract][Full Text] [Related]
14. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states.
Yoshida T; Ozawa Y; Kimura T; Sato Y; Kuznetsov G; Xu S; Uesugi M; Agoulnik S; Taylor N; Funahashi Y; Matsui J
Br J Cancer; 2014 Mar; 110(6):1497-505. PubMed ID: 24569463
[TBL] [Abstract][Full Text] [Related]
15. Study on Attenuating Angiogenesis and Epithelial-Mesenchymal Transition (EMT) of Non-Small Cell Lung Carcinoma (NSCLC) by Regulating MAGEC2.
Jiang S; Liu X; Li D; Yan M; Ju C; Sun J; Jiang F
Technol Cancer Res Treat; 2018 Jan; 17():1533033818797587. PubMed ID: 30198403
[TBL] [Abstract][Full Text] [Related]
16. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
[TBL] [Abstract][Full Text] [Related]
17. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer.
Vijay GV; Zhao N; Den Hollander P; Toneff MJ; Joseph R; Pietila M; Taube JH; Sarkar TR; Ramirez-Pena E; Werden SJ; Shariati M; Gao R; Sobieski M; Stephan CC; Sphyris N; Miura N; Davies P; Chang JT; Soundararajan R; Rosen JM; Mani SA
Breast Cancer Res; 2019 Mar; 21(1):37. PubMed ID: 30845991
[TBL] [Abstract][Full Text] [Related]
18. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
[TBL] [Abstract][Full Text] [Related]
19. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
20. Triple-negative breast cancer metastasis involves complex epithelial-mesenchymal transition dynamics and requires vimentin.
Grasset EM; Dunworth M; Sharma G; Loth M; Tandurella J; Cimino-Mathews A; Gentz M; Bracht S; Haynes M; Fertig EJ; Ewald AJ
Sci Transl Med; 2022 Aug; 14(656):eabn7571. PubMed ID: 35921474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
